Share This

Related Topics News -

     
 Title only   |   Print 
     
三葉草生物-B二價RSV候選疫苗I期臨床試驗獲積極初步數據

2024-04-08T  
《公司業績》三葉草生物-B去年虧損收窄至1.39億人幣 不派末期息

2024-03-27T  
恆指跌幅曾擴至620點 藥股捱沽 榮昌生物急挫21%

2024-01-17T  
醫藥股普遍回吐 來凱及藥明合聯跌逾半成 惟科倫博泰創上市新高

2024-01-12T  
三葉草生物(02197.HK)回應新冠疫苗生產:適時調整業務資源投入

2024-01-11T  
恆指跌近400點 醫藥股普遍捱沽 威高股份及中國中藥齊挫14%

2024-01-08T  
三葉草生物-B(02197.HK)治療血小板減少症藥物臨床試驗獲積極初步數據

2023-12-29T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.